Sulforaphane decreases viability and telomerase activity in hepatocellular carcinoma Hep3B cells through the reactive oxygen species-dependent pathway

Cited 57 time in scopus
Metadata Downloads

Full metadata record

DC FieldValueLanguage
dc.contributor.authorD O Moon-
dc.contributor.authorS H Kang-
dc.contributor.authorK C Kim-
dc.contributor.authorMun-Ock Kim-
dc.contributor.authorY H Choi-
dc.contributor.authorG Y Kim-
dc.date.accessioned2017-04-19T09:19:03Z-
dc.date.available2017-04-19T09:19:03Z-
dc.date.issued2010-
dc.identifier.issn0304-3835-
dc.identifier.uri10.1016/j.canlet.2010.03.009ko
dc.identifier.urihttps://oak.kribb.re.kr/handle/201005/9619-
dc.description.abstractSulforaphane (SFN), a dietary isothiocyanate, is a well known natural product that possesses anti-cancer and chemopreventive activities. However, the molecular mechanism of the anti-telomerase activity of SFN is not well understood. In this study, we investigated the hypothesis that SFN inhibits cell viability and telomerase activity via downregulation of telomerase reverse transcriptase (hTERT) expression. We suggest that elevated intracellular reactive oxygen species (ROS) levels, due to exposure to SFN, has a critical role in abolishing since pretreatment with NAC, an antioxidant, resulted in the recovery of hTERT expression. SFN also suppressed the phosphorylation of Akt (Ser-473), thereby inhibiting hTERT phosphorylation and this effect was reversed by pretreatment with NAC. Taken together, these data suggest that ROS are essential for the suppression of SFN-mediated telomerase activity via transcriptional and posttranslational regulation of hTERT.-
dc.publisherElsevier-
dc.titleSulforaphane decreases viability and telomerase activity in hepatocellular carcinoma Hep3B cells through the reactive oxygen species-dependent pathway-
dc.title.alternativeSulforaphane decreases viability and telomerase activity in hepatocellular carcinoma Hep3B cells through the reactive oxygen species-dependent pathway-
dc.typeArticle-
dc.citation.titleCancer Letters-
dc.citation.number2-
dc.citation.endPage266-
dc.citation.startPage260-
dc.citation.volume295-
dc.contributor.affiliatedAuthorMun-Ock Kim-
dc.contributor.alternativeName문동오-
dc.contributor.alternativeName강상혁-
dc.contributor.alternativeName김기천-
dc.contributor.alternativeName김문옥-
dc.contributor.alternativeName최영현-
dc.contributor.alternativeName김기영-
dc.identifier.bibliographicCitationCancer Letters, vol. 295, no. 2, pp. 260-266-
dc.identifier.doi10.1016/j.canlet.2010.03.009-
dc.subject.keywordReactive oxygen species-
dc.subject.keywordSulforaphane-
dc.subject.keywordTelomerase-
dc.subject.keywordTelomerase reverse transcriptase-
dc.subject.localReactive oxidative species-
dc.subject.localReactive oxygen species(ROS)-
dc.subject.localReactive oxygen species-
dc.subject.localReactive Oxygen Species (ROS)-
dc.subject.localReactive Oxygen Species-
dc.subject.localROS-
dc.subject.localReactive oxygen species (ROS)-
dc.subject.localreactive oxygen species-
dc.subject.localreactive oxygen species (ROS)-
dc.subject.localsulforaphane-
dc.subject.localSulforaphane-
dc.subject.localtelomerase-
dc.subject.localTelomerase-
dc.subject.localTelomerase reverse transcriptase-
dc.description.journalClassY-
Appears in Collections:
Ochang Branch Institute > Natural Product Research Center > 1. Journal Articles
Files in This Item:
  • There are no files associated with this item.


Items in OpenAccess@KRIBB are protected by copyright, with all rights reserved, unless otherwise indicated.